SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.810.0%3:58 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (16968)7/2/2004 7:54:14 AM
From: Robert K.  Read Replies (10) of 17367
 
Kinda hard to believe its usch a large probe. I wonder if all those doses when shipped and stocked in Dallas. If it was life or death for your patient you might be tempted to screw the regs. I really doubt thats the case, but I wonder if its under lock and key.
Regarding the status, the company line is why dont you call Dallas. I guess if they get good results you will know it when you know it. Its almost the forgotten drug in the forgoten trial. I really doubt though that Doc's will so easily let this utility drug go. Its got to be heartwrenching for a doc to watch a kid die knowing full well that something might work. I still think somebody , somewhere will save the day. Unfortunately for many, its now too late. One think to reallly watch is and yet imporved verion of bpi21 (the 10-191(3) i think). The "lack of" drop in BP might be a very interesting and useful attribute (which might be dose limiting now) and it might be something a new partner may wait and negociate for. It would be yet another timeline setback but if it gets the molecule to approval then I am 110% for it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext